Haishan Jiang

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

A phase III clinical trial of PXT3003 in Chinese patients with Charcot-Marie-Tooth disease type 1A.

A phase III clinical trial of PXT3003 in Chinese patients with Charcot-Marie-Tooth disease type 1A.

Journal: iScience
Published: April 15, 2026

NEK1 variants and reduced protein levels in Chinese ALS patients: a descriptive study.

NEK1 variants and reduced protein levels in Chinese ALS patients: a descriptive study.

Journal: Frontiers in aging neuroscience
Published: March 16, 2026

Sequential efgartigimod and ofatumumab for stiff-person syndrome: a case report illustrating a pathophysiology-informed strategy and literature review.

Sequential efgartigimod and ofatumumab for stiff-person syndrome: a case report illustrating a pathophysiology-informed strategy and literature review.

Journal: Frontiers in immunology
Published: February 15, 2026

Macrophage 2 plays an important role in axonal lesions and vasculitis in Sjogren's syndrome complicated with peripheral neuropathy.

Macrophage 2 plays an important role in axonal lesions and vasculitis in Sjogren's syndrome complicated with peripheral neuropathy.

Journal: Clinical rheumatology
Published: August 28, 2025

Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE Trial.

Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE Trial.

Journal: Journal of clinical neurology (Seoul, Korea)
Published: May 08, 2025

Unveiling ten novel SETX mutations: implications for ALS pathogenesis and clinical diversity.

Unveiling ten novel SETX mutations: implications for ALS pathogenesis and clinical diversity.

Journal: Somatosensory & motor research
Published: May 08, 2025

Clinical-pathologic classification of anti-HMGCR-positive immune-mediated necrotizing myopathy.

Clinical-pathologic classification of anti-HMGCR-positive immune-mediated necrotizing myopathy.

Journal: Scientific reports
Published: February 20, 2025

Characterization of nerve biopsy in copper deficiency peripheral neuropathy due to over-treatment of Wilson's disease: A case report.

Characterization of nerve biopsy in copper deficiency peripheral neuropathy due to over-treatment of Wilson's disease: A case report.

Journal: Acta neurologica Belgica
Published: February 11, 2025

A Multicenter Study of Hereditary Transthyretin Amyloidosis in China.

A Multicenter Study of Hereditary Transthyretin Amyloidosis in China.

Journal: Annals of neurology
Published: September 19, 2024

Novel variants and genotype-phenotype correlation in a multicentre cohort of GNE myopathy in China.

Novel variants and genotype-phenotype correlation in a multicentre cohort of GNE myopathy in China.

Journal: Journal of medical genetics
Published: May 30, 2024

The clinical and genetic spectrum of mitochondrial diseases in China: A multicenter retrospective cross-sectional study.

The clinical and genetic spectrum of mitochondrial diseases in China: A multicenter retrospective cross-sectional study.

Journal: Clinical genetics
Published: April 23, 2024

Batoclimab vs Placebo for Generalized Myasthenia Gravis: A Randomized Clinical Trial.

Batoclimab vs Placebo for Generalized Myasthenia Gravis: A Randomized Clinical Trial.

Journal: JAMA neurology
Published: March 04, 2024
Showing 1-12 of 25

Last Updated: 09/26/2026